BioSpace News Archive

Aziyo Biologics, Inc. announced key promotions and new hires that solidify its position as a leader in treatment options for patients receiving implantable medical devices and other surgical procedures.

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that Sarah Tanksley will join its corporate leadership team as Chief Quality Officer, effective October 14.

First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”) today announced the closing of its previously announced public offering of 3,438,396 shares of its common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to an aggregate of 3,438,396 shares of its common stock at an offering price to the public of $1.745 per share (or pre-funded warrant in lieu thereof) and associated warrant.

This week Xiaokui Zhang , Ph.D., Chief Scientific Officer of Aspen Neuroscience, Inc. will present at the 2022 Cell & Gene Meeting on the Mesa Conference in Carlsbad, Calif.

DiscGenics, Inc. today announced that Matthew F. Gornet, MD, Board Certified Spine Surgeon at The Orthopedic Center of St. Louis, will present two-year follow-up data from the Company’s first-in-human clinical study of its allogeneic discogenic progenitor cell therapy (IDCT) for lumbar disc degeneration at the North American Spine Society (NASS) 37th Annual Meeting.

Intermountain Forensics, experts in cold case DNA analysis, announced the addition of a dedicated satellite lab for forensic genetic genealogy with new partner Astrea Forensics.

Todos Medical, Ltd., a comprehensive medical diagnostics and related solutions company, provided a corporate update for shareholders.

EnteroBiotix Limited, the premier full-spectrum microbiome therapeutics company, today announced that it has been granted a Manufacturer’s licence for Investigational Medicinal Products (IMP) by the Medicines and Healthcare Products Regulatory Agency (MHRA) to manufacture microbiome product candidates for clinical trials

BIOMEDevice Boston, the premiere event for medical manufacturing and device engineers, brands, and innovative thought leaders from the region’s top start-ups and medical device OEMs, convened with more than 1,400 attendees and 200-plus exhibitors across the industry under one roof.

Fresenius Kabi announced the successful smart pump interoperability of its Ivenix Infusion System at Fort HealthCare, a regional health care provider in Wisconsin.